drugset / Trial / NCT03693131
Efficacy of MND-2119 in Participants With Hypertriglyceridemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of MND-2119 compared to EPADEL CAPSULES 300 in participants with hypertriglyceridemia.
Timeline
- Start
- 2018-10-27
- Primary completion
- 2019-06-15
- Completion
- 2019-06-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eicosapentaenoic acid | Small molecule | 0.9 g | Oral |
| Subject | Eicosapentaenoic acid | Small molecule | 2 g | Oral |
| Subject | Eicosapentaenoic acid | Small molecule | 4 g | Oral |